Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank86
3Y CAGR+59.7%
5Y CAGR-7.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+59.7%/yr
vs +1.5%/yr prior
5Y CAGR
-7.7%/yr
Recent acceleration
Acceleration
+58.1pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.03 | +615.6% |
| 2024 | 0.00 | -29.2% |
| 2023 | 0.01 | -19.7% |
| 2022 | 0.01 | +1.9% |
| 2021 | 0.01 | -83.9% |
| 2020 | 0.04 | +465.9% |
| 2019 | 0.01 | +14.3% |
| 2018 | 0.01 | -21.2% |
| 2017 | 0.01 | -80.4% |
| 2016 | 0.04 | - |